Skip to main content

Share story

Products

Leonardo DRS raises outlook as funded backlog reaches $5.6bn

Leonardo DRS raises outlook as funded backlog reaches $5.6bn Image: Primary
Leonardo DRS raised its 2026 revenue guidance to $3.95bn-$3.99bn from $3.9bn-$3.98bn after reporting third-quarter revenue of $1.1bn and new funded bookings of $1.6bn. Air Force Technology reported that growth came primarily from tactical radar, naval power and propulsion, and space sensing programmes. Funded backlog reached $5.6bn, up 21% year on year. The company also raised adjusted EBITDA guidance to $545m-$555m from $525m-$540m. Its revised outlook incorporates a lower expected tax rate of 13.0%, compared with 16.5% previously.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Air Force Technology and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Infrastructure
AI Infrastructure

Five technology giants commit more than $3T to future spending

Alphabet, Meta, Microsoft, Amazon and Oracle have committed more than $3T to future spending on data centres, leases, equipment and energy, The Next Web reported, citing Bloomberg. Alphabet accounts for more than $1T and Meta for more than $800B.

Products AI
Products AI

Salesforce's Rune acquisition agreement reportedly worth $375 million

Salesforce's agreement to acquire military logistics software developer Rune Technologies is worth $375 million in cash and stock, Resilience Media reported. Rune builds AI software that helps the US military predict supply needs and manage logistics in the field.

AI Science
AI Science

Insilico says AI-discovered Rentosertib has entered Phase III trials

Insilico Medicine says Rentosertib, its generative AI-discovered drug candidate also known as ISM001-055, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The company described the clinical advance in an announcement carried by News-Medical.Net.